4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0001209191-20-026662
President & CEO bought 165,000 shares at $4.75 ($783,750)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Quinn Anthony G. President & CEO | 2020-04-30 | Purchase | +165,000 | $4.75 | $783,750 | 538,469 | D: show line 1 in the form |
| Open-market purchases · 165,000 sh · avg $4.75 · $783,750 | |||||||
Loading xslF345X03/doc4.xml…